Home > Specialists > Obstetrics and Gynecology > Dr. Mei Yu (俞梅)
Specialty & Clinical Focus:
Chief Physician and Professor of gynecologic oncology at Peking Union Medical College Hospital (PUMCH) in Beijing, with a clinical focus on endometrial, ovarian, cervical and other gynecologic cancers, fertility-preserving therapy, hereditary cancer risk assessment, adolescent gynecologic tumors, and advanced systemic therapies.
Professional Title & Qualifications:
Chief Physician,
Professor,
M.D.
Hospital & Department：
Peking Union Medical College Hospital (PUMCH) – Department of Obstetrics and Gynecology (Gynecologic Oncology Center)
(address: No. 1 Shuaifuyuan, Dongdan, Dongcheng District, Beijing, 100730)
Dr. Mei Yu (俞梅) - Leading Gynecologic Oncologist in Beijing, China
Personal Biography
Dr. Mei Yu is a Chief Physician and Professor at the Gynecologic Oncology Center of Peking Union Medical College Hospital (PUMCH) in Beijing. She completed an eight-year M.D. program at Peking Union Medical College under Academician Lang Jinghe and has worked in the hospital’s Department of Obstetrics and Gynecology since 2004. Her clinical practice focuses on the diagnosis and treatment of gynecologic malignancies, and she performs approximately 400–500 complex Level 3/4 surgeries each year. Dr. Yu was also a visiting scholar at Memorial Sloan Kettering Cancer Center and has contributed to national expert-consensus and guideline work relating to endometrial and cervical cancer, alongside research in ovarian cancer and fertility-preserving care.
Why Choose Dr. Mei Yu (Powered by MedBridgeNZ)
Dr. Mei Yu offers a combination of long-term gynecologic oncology practice at PUMCH, high-volume complex surgical experience, and research involvement across endometrial, ovarian and cervical cancer. Her background also includes fertility-preserving treatment, hereditary cancer risk assessment, adolescent gynecologic tumors, and systemic therapies for recurrent or advanced disease, giving international patients a broad specialist perspective for complex or previously treated cases.
For patients considering care in Beijing, a remote specialist review can clarify the questions that should be addressed before travel. A structured file containing pathology, imaging, operative notes, prior treatment history, relevant molecular or genetic results, and a focused question list helps Dr. Yu’s team review the case efficiently and provide a more useful opinion on possible next steps.
Pre-Travel Case Review & Specialist Liaison
Before organizing travel to Beijing for gynecologic oncology care, international patients can request MedBridgeNZ coordination for a remote specialist review with Dr. Mei Yu. We organize medical-record preparation, translation coordination, a focused question list, and secure client-authorized transfer of the documentation to the relevant PUMCH specialist office.
The specialist office will review the submitted records and provide an opinion, recommendations, and responses to the patient’s questions. MedBridgeNZ then coordinates follow-up communication and helps clarify the administrative requirements, expected timing, and practical travel arrangements before the patient decides whether to pursue an in-person pathway in Beijing.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Mei Yu
Areas of Expertise
Gynecologic Malignancies: Comprehensive diagnosis and individualized treatment for endometrial cancer, ovarian cancer, cervical cancer, vulvar cancer, and uterine sarcoma.
Fertility-Preserving Therapy: Specialized surgical and medical interventions to preserve fertility in young patients with gynecologic cancers.
Genetic Counseling: Risk assessment and management for hereditary gynecologic cancers (e.g., BRCA mutations, Lynch syndrome).
Adolescent Gynecology: Treatment of gynecologic tumors in children and adolescents.
Advanced Therapies: Chemotherapy, targeted therapy (including PARP inhibitors), and immunotherapy for recurrent or advanced cancers.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
3,400 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
2004 – Present: Resident, Attending Physician, Associate Chief Physician, Chief Physician, and Professor at the Department of Obstetrics and Gynecology, Peking Union Medical College Hospital (PUMCH), Beijing, China.
2013 (June – Sept): Visiting Scholar, Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA (focus on gynecologic oncology surgery).
Education & Training
Completed an 8-year M.D. program at Peking Union Medical College under the mentorship of Academician Lang Jinghe.
Awards & Honors
“Healthy Science Popularization Voice” title, China Media Group (2024).
“Special Contribution Individual Award,” 1st Autonomous Region Maternal and Child Health Vocational Skills Competition, Xinjiang (2023).
Outstanding Employee, Peking Union Medical College Hospital (2021).
Medical Achievement Award (Third Prize), Peking Union Medical College Hospital (2018) – for “20 Years of Progress in Diagnosis and Treatment of Rare and Refractory Female Genital Tract Tumors.”
Medical Achievement Team Award (Third Prize), Peking Union Medical College Hospital (2011) – for “Multidisciplinary Treatment of Ovarian Malignancy with Liver and Brain Metastases.”
Academic & Professional Memberships
Committee Member, Chinese Medical Association.
Committee Member and Secretary, Gynecologic Oncology Branch of Beijing Medical Association.
Committee Member, Society of Onco-Endocrinology, China Anti-Cancer Association.
Vice Chair, Women’s Health Branch, China Geriatric Health Care Medicine Research Association.
Standing Committee Member, PUMCH Gynecologic Oncology Special Committee, Beijing Chronic Disease Prevention and Health Education Society.
Medical Dispute Responsibility Assessment Expert, Medical Law Working Committee of Beijing Health Law Society.
Research & Publications
Expert Consensus Leadership: Lead author for “Recommendations on Screening for Endometrial Cancer.” Key contributor to national guidelines on fertility-preserving treatments for endometrial cancer, cervical cancer surgical staging (2023), and breast cancer screening for ovarian cancer patients with BRCA mutations (2022).
Clinical Research: Principal Investigator for studies on PARP inhibitor resistance mechanisms in ovarian cancer and rhTPO treatment for chemotherapy-induced thrombocytopenia.
Genetic Profiling: Pioneered the use of whole-exome sequencing for Sertoli-Leydig cell tumors in Chinese patients to map genetic mutations.
Publications: Published over 40 academic papers in international core journals and participated in the compilation of over 10 obstetrics and gynecology textbooks.
Selected Peer-Reviewed Publications
Yu M, Wang Y, et al. Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma. Front Oncol. 2020;10:1437. PMID: 32983972.
Yuan Z, Huo X, Yu M, et al. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors. Oncologist. 2020;25(9):e1396–e1405. PMID: 32557933.
Yuan Z, Cao D, Yu M, et al. Uterine and Cervical Adenosarcoma: A Retrospective Study of Overall Oncologic Outcomes and Fertility Preservation in Early-Stage Disease. Oncologist. 2019;24(9):e870–e879. PMID: 31127022.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Can Dr. Mei Yu review my gynecologic oncology records before I travel to Beijing?
Yes. MedBridgeNZ can coordinate a remote specialist-review pathway with Dr. Mei Yu for international patients preparing for possible care in Beijing. We help organize existing pathology, imaging, operative notes, treatment history and relevant test results, arrange translation where needed, and transfer the documents with the client’s authorization. Dr. Yu’s specialist office will review the submitted records and provide an opinion, recommendations and responses to the patient’s questions. MedBridgeNZ coordinates the documentation and communication; the medical opinion is provided by the independent specialist or hospital team.
How does the remote specialist review and PUMCH appointment coordination process work?
After the patient submits available records and a focused question list, MedBridgeNZ checks the file for administrative completeness, coordinates translation and sends the authorized documents to the relevant PUMCH specialist office. Dr. Yu’s team reviews the case and returns its opinion and responses through the coordinated pathway. Based on that feedback, MedBridgeNZ can then assist with appointment-request communication and the practical requirements for a possible onsite visit. Appointment timing depends on the hospital’s scheduling process and the pathway selected.
What support is available if Dr. Yu recommends an in-person pathway in Beijing?
If the specialist opinion supports further in-person evaluation or treatment planning in Beijing, MedBridgeNZ can coordinate the next administrative steps. Support may include appointment communication, medical invitation or visa-document coordination, travel and accommodation planning, translation coordination, and non-clinical bilingual administrative assistance during hospital visits. We also help organize updated records and questions for the onsite appointment so the patient arrives with a clear documentation package. Medical decisions and care are provided by the relevant hospital and licensed clinicians.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-led gynecologic oncology pathways in Beijing. We coordinate appointment requests, medical-record preparation, translation, client-authorized document transfer, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative assistance. We do not provide medical advice, diagnosis, or treatment. Clinical opinions and recommendations are provided by the relevant independent hospital or licensed specialist, and third-party medical and travel costs remain separate unless expressly stated in writing.